Insulin Delivery Devices Market By Product Type (Insulin Pens {Reusable Insulin Pens and Disposable Insulin Pens}, Insulin Pumps {Patch Pumps and Tethered Pumps}, Insulin Pen Needles {Standard Pen Needles and Safety Pen Needles}, Insulin Syringes, and Other Products), By Application (Type I Diabetes, Type II Diabetes, and Gestational Diabetes), By End-User (Hospitals & Clinics, Homecare, and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Insulin Pens
  • Reusable Insulin Pens
  • Disposable Insulin Pens
• Insulin Pumps
  • Patch Pumps
  • Tethered Pumps
• Insulin Pen Needles
  • Standard Pen Needles
  • Safety Pen Needles
• Insulin Syringes
• Other Products

By Application

• Type I Diabetes
• Type II Diabetes
• Gestational Diabetes

By End-User

• Hospitals & Clinics
• Homecare
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Medtronic plc
• Novo Nordisk A/S
• Sanofi
• Eli Lilly and Company
• Insulet Corporation
• F. Hoffmann-La Roche AG
• Ypsomed AG
• Tandem Diabetes Care, Inc.
• Becton, Dickinson and Company (BD)
• Abbott Laboratories
• Dexcom, Inc.
• Animas Corporation (a Johnson & Johnson company)
• Cellnovo Group SA
• SOOIL Developments Co., Ltd.
• Valeritas, Inc.